Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Lawrence Poree

Interventional Pain Medicine San Francisco, CA Medical Doctor

NPI 1457391922 CMS profile 247659

2255 Post St, San Francisco, CA 94115

Open in the dashboard

General payments

$110,767

164 records reported · program years 2019–2025

Research payments

$693

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$21,132 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Lawrence Poree of San Francisco, CA is reported in the CMS Open Payments database as having received $110,767 across 164 general payments and $693 in research payments paid to them. Separately, studies naming them as principal investigator received $21,132 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 96th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,742 11
2024 General $18,765 46
2023 General $34,327 34
2022 General $32,334 29
2021 General $4,201 9
2021 Research $231 4
2020 General $15,900 17
2020 Research $81 1
2019 General $2,497 18
2019 Research $381 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Lawrence Poree
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Lawrence Poree were reported at $2,742. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Lawrence Poree Interventional Pain Medicine median Middle half National median
2019 $2,497 $684 $216–$2,079 $163
2020 $15,900 $382 $122–$1,109 $114
2021 $4,201 $552 $167–$1,554 $132
2022 $32,334 $605 $187–$1,924 $149
2023 $34,327 $671 $195–$1,915 $160
2024 $18,765 $684 $206–$1,837 $164
2025 $2,742 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Saluda Medical Americas, Inc. $80,421 82 payments
  2. Nalu Medical, Inc. $9,208 6 payments
  3. Medtronic USA, Inc. $8,803 11 payments
  4. Medtronic, Inc. $7,447 24 payments
  5. Vertiflex, Inc. $1,902 8 payments
  6. MML US, Inc. $923 4 payments
  7. Abbott Laboratories $545 6 payments
  8. Nevro Corp. $437 4 payments
  9. BIOTRONIK NRO, Inc. $334 4 payments
  10. Stryker Corporation $265 4 payments
  11. Other $480 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $80,551 38 payments
  2. Travel and Lodging $12,379 32 payments
  3. Current or prospective ownership or investment interest $8,958 5 payments
  4. Food and Beverage $8,859 88 payments
  5. Education $19 1 payment
Products named General payments · program years 2019–2025
  1. Evoke SCS $63,015 55 payments
  2. Evoke $17,406 27 payments
  3. Nalu Neurostimulation System $9,208 6 payments
  4. VECTRIS $2,188 2 payments
  5. Superion ISS $1,902 8 payments
  6. INTELLIS ADAPTIVESTIM $1,574 16 payments
  7. ReActiv8 $923 4 payments
  8. RESTORE $310 1 payment
  9. ETERNA $252 2 payments
  10. Senza $237 2 payments
  11. Other $2,101 33 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Saluda Medical Americas, Inc. $693 10 payments

Billing to Medicare

Part B · data year 2024 · 48 billing codes

Paid by Medicare

$69,403

Medicare's payments for the services billed

Medicare patients

157

Average age 69

Services billed

1,036

98 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 68%
Depression 48%
Chronic kidney disease 28%
Diabetes 24%
Osteoporosis 22%
COPD 20%
Ischemic heart disease 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record